Resolution of islet and acinar lineages during embryogenesis

胚胎发生过程中胰岛和腺泡谱系的解析

• 批准号: 7056484
• 负责人: RAYMOND J. MACDONALD
• 金额: $ 37.05万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-08-01 至 2010-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7056484
• 关键词: acinar cell; cooperative study; developmental genetics; embryogenesis; histogenesis; laboratory mouse; laboratory rat; pancreas; pancreatic islets; transcription factor

Renewable sources of insulin-producing beta-cells for transplantation therapy of diabetes mellitus will most likely derive from the managed development of surrogate cells, such as embryonic or adult 'stem' cells. This goal would be facilitated greatly by a thorough understanding of the extrinsic morphogens and cell-autonomous factors that control embryonic pancreatic development. P48/PTF1A is a pancreas-restricted bHLH transcription factor originally thought to functional selectively in specifying acinar cell fate. Recently P48/PTF1A has been shown to be required for the formation of islet as well as acinar tissue, and mutations in the human gene cause permanent neonatal diabetes mellitus (PNDM). The functional form of P48 in pancreatic acinar cells is the heterotrimeric PTF1 complex. We have discovered that PTF1 from adult pancreas comprises P48, one of the common E proteins (E12, E47 or HEB), and SUH-L (aka RBP-Jk), a mammalian homologue of Drosophila Su(H). We have shown that the Notch-responsive mammalian orthologue of Su(H) (SUH) can also form a trimeric complex with P48 and an E protein and as well as with their evolutionarily conserved Drosophila orthologues. The human PNDM nonsense mutations delete the C-terminal region of P48, which we have shown is required for interactions with SUH and SUH-L, and therefore would not be able to form the trimeric PTF1 complex. We propose that PTF1 containing either SUH or SUH-L and in concert with Notch-signaling may control cell-fate decisions during the 'secondary transition' of pancreatic organogenesis. We will test this through three Specific Aims. Aim 1 will use a genetic approach for depleting P48 at different developmental stages in utero to determine which developmental processes require P48 and to identify direct P48-target genes. Aims 2 and 3 will determine which of the P48-dependent processes also require SUH or SUH-L and whether that requirement includes their participation in a PTF1 complex, as predicted.

用于糖尿病移植治疗的产生胰岛素的β细胞的可再生来源最有可能来自有管理的替代细胞的发育，如胚胎或成体“干细胞”。彻底了解控制胚胎胰腺发育的外在形态因子和细胞自主因子，将极大地促进这一目标。P48/PTF1A是一种胰腺限制性bHLH转录因子，最初被认为具有选择性地指定腺泡细胞命运的功能。最近，P48/PTF1A已被证明是胰岛和腺泡组织形成所必需的